The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach
ConclusionsProgression in fibrosing ILD causes a significant impact on QoL and HCRU and costs. These survey data underline the need for safe and effective therapies to slow the disease progression.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Interstitial Lung Disease